CLDN1 and irritable bowel syndrome: Moreover, in IBS-D patients, increased levels of miRNA-29a and miRNA-29b have been described together with a reduction of CLDN1, ZO-1 and nuclear factor-kB repressing factor, while increased levels have also been observed in mice models of IBS or colitis (113, 419).